Israel’s Pharma Two B (see here in 2015) has successfully completed the Phase 3 human trial of its P2B001 treatment for Parkinson’s Disease. The trial met its primary and key secondary endpoints, and the company can now prepare for US … Continue reading →

18 COVID-19 patients hospitalized with moderate or severe symptoms were treated with Amor-18 from Israel’s Amorphical (see here previously). All recovered and were discharged in a few days. https://www.jpost.com/health-and-wellness/coronavirus/article-689543 https://www.amorphical.com/ongoing-clinical-research/

Israel’s Binah.ai (see here previously) has come a long way in the last 18 months. Some 50 million customers of the world’s top insurance companies now use Binah’s remote health and wellness monitoring platform to measure vital signs, from the … Continue reading →

Israel’s AiVF (see here previously) has received regulatory approval to sell its IVF analysis platform product in the United Kingdom – one of the largest IVF markets in Europe. It can predict, without the need for a biopsy, whether a … Continue reading →

The virtual reality simulator from Israel’s DecideVR identifies decision-making errors by doctors in medical treatment in intensive care units (ICU). The platform, developed by Professor Alex Mintz, formerly of Herzliya’s Reichman University, currently focuses on life-saving cardiovascular decisions. https://www.calcalistech.com/ctech/articles/0,7340,L-3925317,00.html https://www.youtube.com/watch?v=J1juJL6YSX0

Israel’s Nanox (see here previously) has delivered the first of its next-generation X-ray machines to Israel’s Shamir Medical Center in Tzifrin. The Nanox.ARC uses low-radiation X-rays to produce high-resolution 3-D digital images, previously only available from expensive CT scans. https://www.jpost.com/health-and-wellness/first-in-world-pilot-of-new-x-ray-machine-to-fast-diagnose-covid-pneumonia-687614

Scientists at Haifa University and the Technion Institute have found a link between bacteria in the gut and sleep patterns.  Those that eat fatty foods tend to be night owls, whereas those that have a high fiber diet tend to … Continue reading →

The partnership between Israel’s Datos Health and Israel’s Sheba Medical Center has progressed to at-home monitoring of babies born with complex heart malformations. Babies monitored include in the Palestinian Authority, Gaza, Iraq, Kurdistan, and Cyprus. https://www.israel21c.org/babies-with-fragile-hearts-now-can-be-monitored-remotely/ https://datos-health.com/

Israel’s ImmunoBrain Checkpoint (see here previously) has been awarded a grant of $5 million over 3 years to support human clinical trials of IBC-Ab002, for the treatment of Alzheimer’s disease. Development was based on Weizmann Institute immune system studies. https://www.weizmann-usa.org/news-media/in-the-news/immunobrain-checkpoint-awarded-5-million-us-nia-grant-for-phase-1b-alzheimer-s-disease/